Search

everythinglearnresearchcommunity

for

Search:↓

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Balding and low testosterone increase risk of urinary stones.

Low vitamin D levels are linked to hair loss, and vitamin D might help treat it.

There is no causal relationship between androgenetic alopecia and serum uric acid.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Lower vitamin D levels are linked to more severe hair loss in men.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Low vitamin D levels are linked to increased risk of male pattern baldness.

Microneedle therapy combined with serum effectively increases hair count in people with hair loss, with no side effects.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

Higher sebum levels are linked to more severe male baldness.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

The serum increased hair density and was well-tolerated, but didn't affect hair thickness or shedding.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Low PON1 levels may indicate and predict the severity of hair loss.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

Smoking and drinking can lower vitamin levels and potentially trigger early hair loss, but overall vitamin levels don't seem to affect hair loss duration.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Men with androgenetic alopecia may have higher cholesterol and triglycerides.

People with early onset hair loss (Androgenetic Alopecia) in Ile-Ife, Nigeria, have significantly lower iron levels compared to those with adult-onset hair loss.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Men with early hair loss have lower vitamin D levels.